Return to site
Return to site

RNA Activation Technology Startup Ractigen Therapeutics Completed A+ Round Financing

· Trends

Racigen Therapeutics, a global innovative small nucleic acid drug development startup, announced the completion of nearly 200 million yuan of A+ round financing. This round of financing will be mainly used to promote several preclinical projects to the clinical stage, expand nucleic acid production capacity and accelerate the process of internationalization.

 

As a novel gene-targeting platform technology, saRNA drugs activate gene expression via a mechanism known as RNA activation (RNAa) boosting protein levels in diseases caused by insufficient protein expression. RNAa is a biological mechanism first discovered and named in 2006 by Dr. Long-Cheng Li, co-founder of Ractigen Therapeutics.

 

Since its establishment in 2017, Racigen Therapeutics has actively promoted more than ten saRNA drug R&D pipelines in just over four years. Pipeline indications cover genetic diseases, tumors, liver targets, central nervous system, ophthalmic diseases and other fields. At present, four pipelines are in preclinical development stage. At the same time, the company has built two key technology platforms of "Smart-TTC" and "SCAD" with independent intellectual property rights.

 

 

Subscribe
Previous
Synthetic Biology Startup PhaBuilder Completed A Round of...
Next
DNA Storage Technology Startup DigiCodon Completed Pre-A...
 Return to site
Cookie Use
We use cookies to improve browsing experience, security, and data collection. By accepting, you agree to the use of cookies for advertising and analytics. You can change your cookie settings at any time. Learn More
Accept all
Settings
Decline All
Cookie Settings
Necessary Cookies
These cookies enable core functionality such as security, network management, and accessibility. These cookies can’t be switched off.
Analytics Cookies
These cookies help us better understand how visitors interact with our website and help us discover errors.
Preferences Cookies
These cookies allow the website to remember choices you've made to provide enhanced functionality and personalization.
Save